Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.

Cierna Z, Miskovska V, Roska J, Jurkovicova D, Pulzova LB, Sestakova Z, Hurbanova L, Machalekova K, Chovanec M, Rejlekova K, Svetlovska D, Kalavska K, Kajo K, Babal P, Mardiak J, Ward TA, Mego M, Chovanec M.

BMC Cancer. 2020 Jan 6;20(1):17. doi: 10.1186/s12885-019-6496-1.

2.

Correction of Dyssynergic Defecation, but not Fiber Supplementation, Reduces Symptoms of Functional Dyspepsia in Patients With Constipation in a Randomized Trial.

Huaman JW, Mego M, Bendezú A, Monrroy H, Samino S, Accarino A, Saperas E, Azpiroz F.

Clin Gastroenterol Hepatol. 2019 Dec 4. pii: S1542-3565(19)31388-6. doi: 10.1016/j.cgh.2019.11.048. [Epub ahead of print]

3.

Glycan Analysis as Biomarkers for Testicular Cancer.

Hires M, Jane E, Mego M, Chovanec M, Kasak P, Tkac J.

Diagnostics (Basel). 2019 Oct 22;9(4). pii: E156. doi: 10.3390/diagnostics9040156. Review.

4.

Liquid biopsy in germ cell tumors: biology and clinical management.

Chovanec M, Kalavska K, Mego M, Cheng L.

Expert Rev Mol Diagn. 2019 Oct 29:1-8. doi: 10.1080/14737159.2019.1685383. [Epub ahead of print]

PMID:
31652083
5.

Atherosclerosis in cancer patients.

Mladosievicova B, Petrikova L, Valaskova Z, Bernadic M Jr, Chovanec M, Mego M, Bernadic M Sr.

Bratisl Lek Listy. 2019;120(9):636-640. doi: 10.4149/BLL_2019_105.

PMID:
31475545
6.

Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer.

De Giorgi U, Mego M, Scarpi E, Giordano A, Giuliano M, Valero V, Alvarez RH, Ueno NT, Cristofanilli M, Reuben JM.

Ther Adv Med Oncol. 2019 Aug 14;11:1758835919866065. doi: 10.1177/1758835919866065. eCollection 2019.

7.

Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells.

Schmidtova S, Kalavska K, Gercakova K, Cierna Z, Miklikova S, Smolkova B, Buocikova V, Miskovska V, Durinikova E, Burikova M, Chovanec M, Matuskova M, Mego M, Kucerova L.

Cancers (Basel). 2019 Aug 22;11(9). pii: E1224. doi: 10.3390/cancers11091224.

8.

High Endogenous DNA Damage Levels Predict Hematological Toxicity in Testicular Germ Cell Tumor Patients Treated With First-Line Chemotherapy.

Hapakova N, Sestakova Z, Holickova A, Hurbanova L, Miskovska V, Chovanec M, Rejlekova K, Svetlovska D, Kalavska K, Obertova J, Palacka P, Sycova-Mila Z, Mardiak J, Chovanec M, Mego M.

Clin Genitourin Cancer. 2019 Oct;17(5):e1020-e1025. doi: 10.1016/j.clgc.2019.06.004. Epub 2019 Jun 13.

PMID:
31281064
9.

Intraoperative tumor lysis syndrome in a giant teratoma: a case report.

Pindak D, Rejlekova K, Tomas M, Aziri R, Rovenska E, Puskacova J, Mego M.

BMC Surg. 2019 Jun 14;19(1):62. doi: 10.1186/s12893-019-0526-4.

10.

Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support.

De Padova S, Casadei C, Berardi A, Bertelli T, Filograna A, Cursano MC, Menna C, Burgio SL, Altavilla A, Schepisi G, Prati S, Montalti S, Chovanec M, Banna GL, Grassi L, Mego M, De Giorgi U.

Front Endocrinol (Lausanne). 2019 May 28;10:318. doi: 10.3389/fendo.2019.00318. eCollection 2019. Review.

11.

Immune mechanisms and possible immune therapy in testicular germ cell tumours.

Chovanec M, Mardiak J, Mego M.

Andrology. 2019 Jul;7(4):479-486. doi: 10.1111/andr.12656. Epub 2019 Jun 6. Review.

PMID:
31169364
12.

Phase II study of avelumab in multiple relapsed/refractory germ cell cancer.

Mego M, Svetlovska D, Chovanec M, Rečkova M, Rejlekova K, Obertova J, Palacka P, Sycova-Mila Z, De Giorgi U, Mardiak J.

Invest New Drugs. 2019 Aug;37(4):748-754. doi: 10.1007/s10637-019-00805-4. Epub 2019 Jun 1.

PMID:
31152292
13.

Severe Complications in Testicular Germ Cell Tumors: The Choriocarcinoma Syndrome.

Rejlekova K, Cursano MC, De Giorgi U, Mego M.

Front Endocrinol (Lausanne). 2019 Apr 12;10:218. doi: 10.3389/fendo.2019.00218. eCollection 2019. Review.

14.

Leptomeningeal Metastasis in a Breast Cancer Treated with Two Lines of Intrathecal Chemotherapy - a Case Report.

Mikudova V, Rejlekova K, Gyarfas J, Oravcova I, Chovanec M, Mardiak J, Mego M.

Klin Onkol. 2019 Spring;32(2):139-142. doi: 10.14735/amko2018139.

PMID:
30995855
15.

Clinical Management and Outcome in Extreme Retroperitoneal Growing Teratoma Syndrome of Testicular Origin - Clinical Management and Effect of the Treatment.

Huľová S, Aziri R, Chovanec M, Mardiak J, Mego M, Pinďák D.

Klin Onkol. 2019 Spring;32(2):129-132. doi: 10.14735/amko2019129.

PMID:
30995853
16.

Circulating Tumor Cells With Epithelial-to-mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer.

Mego M, Karaba M, Minarik G, Benca J, Silvia J, Sedlackova T, Manasova D, Kalavska K, Pindak D, Cristofanilli M, Reuben JM, Mardiak J.

Anticancer Res. 2019 Apr;39(4):1829-1837. doi: 10.21873/anticanres.13290.

PMID:
30952723
17.

Reclassification of good-risk seminoma: prognostic factors, novel biomarkers and implications for clinical management.

Casadei C, Schepisi G, Menna C, Chovanec M, Gurioli G, Gallà V, Altavilla A, Marcellini M, Bellia SR, Lolli C, Mego M, Rosti G, De Giorgi U.

Future Oncol. 2019 Apr;15(12):1347-1352. doi: 10.2217/fon-2018-0850. Epub 2019 Mar 18. Review.

PMID:
30880465
18.

A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease-free survival in low-risk breast cancer patients.

Zmetakova I, Kalinkova L, Smolkova B, Horvathova Kajabova V, Cierna Z, Danihel L, Bohac M, Sedlackova T, Minarik G, Karaba M, Benca J, Cihova M, Buocikova V, Miklikova S, Mego M, Fridrichova I.

Cancer Sci. 2019 May;110(5):1695-1704. doi: 10.1111/cas.13985. Epub 2019 Mar 18.

19.

Emerging Prognostic Biomarkers in Testicular Germ Cell Tumors: Looking Beyond Established Practice.

Chovanec M, Albany C, Mego M, Montironi R, Cimadamore A, Cheng L.

Front Oncol. 2018 Nov 28;8:571. doi: 10.3389/fonc.2018.00571. eCollection 2018.

20.

Dia-gnostic Challenges and Extraordinary Treatment Response in Rare Malignant PEComa Tumor of the Kidney.

Huľová S, Sycova-Mila Z, Macák D, Janega P, Chovanec M, Mardiak J, Mego M.

Klin Onkol. Fall 2018;31(6):448-452. doi: 10.14735/amko2018448.

PMID:
30545225
21.

Lymphoma transformation of tumor infiltrating lymphocytes observed in testicular patient‑derived xenograft models.

Kalavska K, Kucerova L, Schmidtova S, Toro L, Kozovska Z, Plank L, Chovanec M, Palacka P, Pindak D, Macak D, Mardiak J, Mego M.

Oncol Rep. 2018 Dec;40(6):3593-3602. doi: 10.3892/or.2018.6769. Epub 2018 Oct 5.

PMID:
30542732
22.

Clinical utility of plasma miR-371a-3p in germ cell tumors.

Mego M, van Agthoven T, Gronesova P, Chovanec M, Miskovska V, Mardiak J, Looijenga LHJ.

J Cell Mol Med. 2019 Feb;23(2):1128-1136. doi: 10.1111/jcmm.14013. Epub 2018 Dec 7.

23.

βcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors.

Chovanec M, Cierna Z, Miskovska V, Machalekova K, Kalavska K, Rejlekova K, Svetlovska D, Macak D, Spanik S, Kajo K, Babal P, Mego M, Mardiak J.

BMC Cancer. 2018 Nov 3;18(1):1062. doi: 10.1186/s12885-018-4929-x.

24.

Prognostic value of various subtypes of extracellular DNA in ovarian cancer patients.

Kalavska K, Minarik T, Vlkova B, Manasova D, Kubickova M, Jurik A, Mardiak J, Sufliarsky J, Celec P, Mego M.

J Ovarian Res. 2018 Sep 22;11(1):85. doi: 10.1186/s13048-018-0459-z.

25.

Decreased methylation in the SNAI2 and ADAM23 genes associated with de-differentiation and haematogenous dissemination in breast cancers.

Kalinkova L, Zmetakova I, Smolkova B, Minarik G, Sedlackova T, Horvathova Kajabova V, Cierna Z, Mego M, Fridrichova I.

BMC Cancer. 2018 Sep 6;18(1):875. doi: 10.1186/s12885-018-4783-x.

26.

Duodenal obstruction due to intramural haematoma as a complication of endoscopic biopsy.

Mego M, Lugo N, Roura J, Saperas E.

Gastroenterol Hepatol. 2019 Jun - Jul;42(6):381-382. doi: 10.1016/j.gastrohep.2018.07.011. Epub 2018 Aug 25. English, Spanish. No abstract available.

PMID:
30153947
27.

Effects of Prebiotics vs a Diet Low in FODMAPs in Patients With Functional Gut Disorders.

Huaman JW, Mego M, Manichanh C, Cañellas N, Cañueto D, Segurola H, Jansana M, Malagelada C, Accarino A, Vulevic J, Tzortzis G, Gibson G, Saperas E, Guarner F, Azpiroz F.

Gastroenterology. 2018 Oct;155(4):1004-1007. doi: 10.1053/j.gastro.2018.06.045. Epub 2018 Jun 30.

PMID:
29964041
28.

A unique clinical presentation of de novo acute promyelocytic leukemia as a myeloid sarcoma of the breast.

Oravcova I, Mikuskova E, Leitnerova M, Gyarfas J, Mlcakova A, Szepe P, Plank L, Demitrovicova L, Mikudova V, Cingelova S, Mego M, Drgona L.

Int J Hematol. 2018 Nov;108(5):550-553. doi: 10.1007/s12185-018-2479-2. Epub 2018 Jun 21.

PMID:
29931624
29.

Immune-Related Concepts in Biology and Treatment of Germ-Cell Tumors.

Chovanec M, De Giorgi U, Mego M.

Adv Urol. 2018 Mar 13;2018:3718165. doi: 10.1155/2018/3718165. eCollection 2018. Review.

30.

Systemic immune-inflammation index in germ-cell tumours.

Chovanec M, Cierna Z, Miskovska V, Machalekova K, Kalavska K, Rejlekova K, Svetlovska D, Macak D, Spanik S, Kajo K, Babal P, De Giorgi U, Mego M, Mardiak J.

Br J Cancer. 2018 Mar 20;118(6):831-838. doi: 10.1038/bjc.2017.460. Epub 2018 Feb 27.

31.

Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors.

Chovanec M, Vasilkova L, Setteyova L, Obertova J, Palacka P, Rejlekova K, Sycova-Mila Z, Kalavska K, Svetlovska D, Cingelova S, Mladosievicova B, Mardiak J, Mego M.

Oncologist. 2018 May;23(5):617-623. doi: 10.1634/theoncologist.2017-0457. Epub 2018 Jan 19.

32.

Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical Implications.

Kalavska K, Conteduca V, De Giorgi U, Mego M.

Curr Cancer Drug Targets. 2018;18(10):967-978. doi: 10.2174/1568009618666180102103959. Review.

PMID:
29295694
33.

Undifferentiated Carcinoma of the Pancreas - a Case Report.

Kašperová B, Jurišová S, Macúch J, Bumberová M, Janega P, Dolinský J, Mego M.

Klin Onkol. 2018 Winter;31(6):453-456. doi: 10.14735/amko2018453.

PMID:
31035768
34.

Down-regulation of traditional oncomiRs in plasma of breast cancer patients.

Jurkovicova D, Smolkova B, Magyerkova M, Sestakova Z, Kajabova VH, Kulcsar L, Zmetakova I, Kalinkova L, Krivulcik T, Karaba M, Benca J, Sedlackova T, Minarik G, Cierna Z, Danihel L, Mego M, Chovanec M, Fridrichova I.

Oncotarget. 2017 Aug 24;8(44):77369-77384. doi: 10.18632/oncotarget.20484. eCollection 2017 Sep 29.

35.

The Chest Wall Tumor as a Rare Clinical Presentation of Hepatocellular Carcinoma Metastasis.

Porsok S, Mego M, Pinďák D, Duchoň R, Beniak J, Mardiak J.

Klin Onkol. Summer 2017;30(4):299-301. doi: 10.14735/amko2017299.

PMID:
28832177
36.

Circulating tumor cells and coagulation-Minireview.

Bystricky B, Reuben JM, Mego M.

Crit Rev Oncol Hematol. 2017 Jun;114:33-42. doi: 10.1016/j.critrevonc.2017.04.003. Epub 2017 Apr 6. Review.

PMID:
28477745
37.

Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.

Bystricky B, Cierna Z, Sieberova G, Janega P, Karaba M, Minarik G, Benca J, Sedlackova T, Jurisova S, Gronesova P, Pindak D, Macuch J, Mardiak J, Mego M.

Anticancer Res. 2017 May;37(5):2727-2734.

PMID:
28476852
38.

Prognostic value of intratumoral carbonic anhydrase IX expression in testicular germ cell tumors.

Kalavska K, Cierna Z, Chovanec M, Takacova M, Svetlovska D, Miskovska V, Obertova J, Palacka P, Rajec J, Sycova-Mila Z, Machalekova K, Kajo K, Spanik S, Mardiak J, Babal P, Pastorekova S, Mego M.

Oncol Lett. 2017 Apr;13(4):2177-2185. doi: 10.3892/ol.2017.5745. Epub 2017 Feb 14.

39.

Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors.

Chovanec M, Cierna Z, Miskovska V, Machalekova K, Svetlovska D, Kalavska K, Rejlekova K, Spanik S, Kajo K, Babal P, Mardiak J, Mego M.

Oncotarget. 2017 Mar 28;8(13):21794-21805. doi: 10.18632/oncotarget.15585.

40.

Colonic gas homeostasis: Mechanisms of adaptation following HOST-G904 galactooligosaccharide use in humans.

Mego M, Accarino A, Tzortzis G, Vulevic J, Gibson G, Guarner F, Azpiroz F.

Neurogastroenterol Motil. 2017 Sep;29(9). doi: 10.1111/nmo.13080. Epub 2017 Apr 18.

PMID:
28418214
41.

Relationship Between Circulating Tumor Cells and Tissue Plasminogen Activator in Patients with Early Breast Cancer.

Bystricky B, Jurisova S, Karaba M, Minarik G, Benca J, Sedlácková T, Tothova L, Vlkova B, Cierna Z, Janega P, Manasova D, Gronesova P, Pindak D, Mardiak J, Celec P, Mego M.

Anticancer Res. 2017 Apr;37(4):1787-1791.

PMID:
28373442
42.

Novel strategies for comprehensive mutation screening of the APC gene.

Wachsmannova L, Mego M, Stevurkova V, Zajac V, Ciernikova S.

Neoplasma. 2017;64(3):338-343. doi: 10.4149/neo_2017_303. Review.

PMID:
28253712
43.

Plasma Cytokines Correlated With Disease Characteristics, Progression-Free Survival, and Overall Survival in Testicular Germ-Cell Tumor Patients.

Svetlovska D, Miskovska V, Cholujova D, Gronesova P, Cingelova S, Chovanec M, Sycova-Mila Z, Obertova J, Palacka P, Rajec J, Kalavska K, Usakova V, Luha J, Ondrus D, Spanik S, Mardiak J, Mego M.

Clin Genitourin Cancer. 2017 Jun;15(3):411-416.e2. doi: 10.1016/j.clgc.2017.01.027. Epub 2017 Feb 8.

PMID:
28237180
44.

Differences in Incidence and Biological Characteristics of Breast Cancer between Roma and Non-Roma Patients in Slovakia.

Reckova M, Mardiak J, Plank L, Vulevova M, Cingelová S, Mego M.

Klin Onkol. Winter 2017;30(1):48-54. doi: 10.14735/amko201748.

PMID:
28185465
45.

Differences in Age-distribution, Oncological Diagnoses and Stage in Roma and Non-Roma Cancer Patients Registered at the Outpatient Oncology Department Poprad in 2014 and 2015 - a Retrospective Study.

Reckova M, Mardiak J, Beniak J, Kakalejcik M, Medvecova L, Cingelová S, Mego M.

Klin Onkol. Winter 2017;30(1):41-47. doi: 10.14735/amko201741.

PMID:
28185464
46.

Metabolic adaptation of colonic microbiota to galactooligosaccharides: a proof-of-concept-study.

Mego M, Manichanh C, Accarino A, Campos D, Pozuelo M, Varela E, Vulevic J, Tzortzis G, Gibson G, Guarner F, Azpiroz F.

Aliment Pharmacol Ther. 2017 Mar;45(5):670-680. doi: 10.1111/apt.13931. Epub 2017 Jan 12.

47.

High-resolution manometry in patients with idiopathic inflammatory myopathy: Elevated prevalence of esophageal involvement and differences according to autoantibody status and clinical subset.

Casal-Dominguez M, Pinal-Fernandez I, Mego M, Accarino A, Jubany L, Azpiroz F, Selva-O'callaghan A.

Muscle Nerve. 2017 Sep;56(3):386-392. doi: 10.1002/mus.25507. Epub 2017 Apr 4.

PMID:
27935079
48.

High-Grade Neuroendocrine Carcinoma of the Breast With Focal Squamous Differentiation.

Mečiarová I, Sojáková M, Mego M, Mardiak J, Pohlodek K.

Int J Surg Pathol. 2016 Dec;24(8):738-742. Epub 2016 Jun 27.

PMID:
27353078
49.

The prognostic value of DNA damage level in peripheral blood lymphocytes of chemotherapy-naïve patients with germ cell cancer.

Sestakova Z, Kalavska K, Hurbanova L, Jurkovicova D, Gursky J, Chovanec M, Svetlovska D, Miskovska V, Obertova J, Palacka P, Rejlekova K, Sycova-Mila Z, Cingelova S, Spanik S, Mardiak J, Chovanec M, Mego M.

Oncotarget. 2016 Nov 15;7(46):75996-76005. doi: 10.18632/oncotarget.12515.

50.

Prognostic value of serum carbonic anhydrase IX in testicular germ cell tumor patients.

Kalavska K, Chovanec M, Zatovicova M, Takacova M, Gronesova P, Svetlovska D, Baratova M, Miskovska V, Obertova J, Palacka P, Rajec J, Sycova-Mila Z, Cierna Z, Kajo K, Spanik S, Babal P, Mardiak J, Pastorekova S, Mego M.

Oncol Lett. 2016 Oct;12(4):2590-2598. Epub 2016 Aug 16.

Supplemental Content

Support Center